Needham reiterates Zeta Global stock rating on strong AI growth By Investing.com

Zeta Global reported Q1 revenue of $396 million, up 50% year over year and 7.01% above forecasts, marking its 19th consecutive quarter of revenue beats. Organic revenue growth accelerated to 29%, while the Marigold acquisition beat expectations by $8 million and Athena AI helped secure the company’s largest deal to date. Needham reiterated a Buy rating and $25 target, and RBC raised its target to $29 on stronger AI traction, though fiscal 2026 guidance implies growth slows to about 20% for the rest of the year.

Analysis

ZETA’s print is less about a single quarter and more about proof that its data/AI stack is moving from narrative to monetization. The key second-order effect is that higher ARPU and larger deal size usually imply better net retention and sales efficiency, which can extend revenue durability even if top-line growth moderates from the current pace. That matters because the market typically awards platform names a premium only when growth is both fast and increasingly self-funded; ZETA is inching closer to that threshold, which could force multiple expansion if profitability arrives on schedule.

The bigger competitive implication is that AI is becoming a budget reallocation tool, not just a feature checklist. If ZETA is winning larger deals with AI-led messaging, that pressures adjacent martech/adtech vendors that still sell point solutions and weakens pricing power for slower-moving public comps. It also raises the odds of tuck-in M&A across the sector as incumbents try to buy AI capability rather than build it, which could support valuations for other differentiated data platforms over the next 6–12 months.

The main risk is that the market may already be extrapolating the first-half beat into a straight-line story, while guidance still implies a meaningful growth deceleration over the next several quarters. If macro ad spend softens or the Marigold benefit normalizes faster than expected, the stock could de-rate quickly because the current setup is momentum-dependent. In that sense, the trade is more vulnerable to a three-month tape break than a one-year fundamental break.

Contrarian view: the consensus may be underestimating how much of the re-rating has already been pulled forward by AI enthusiasm. If the next couple of quarters show growth holding near 20% rather than re-accelerating, the name can still be fundamentally strong but structurally capped by “good, not great” software multiples. The opportunity is to own the optionality, but not to assume the market will pay growth-stock valuations forever without a clean profitability inflection.

Key Decisions for Investors

• Long ZETA into any post-earnings digestion over the next 1-3 weeks; use weakness toward the low-20s as entry, targeting a re-rate toward the mid/high-20s if profitability visibility improves. Risk: if growth normalizes faster than expected, the stock can retrace to prior support quickly.
• Buy ZETA call spreads 3-6 months out to capture upside from AI monetization while capping premium bleed. Favor structures that pay off if the market starts pricing a 2026 earnings path rather than just another beat.
• Pair trade: long ZETA / short a slower-growth martech peer or basket over 1-2 quarters. The thesis is that AI-led deal wins will increasingly separate data-rich platforms from generic software names; risk is broad multiple compression in SaaS.
• If already long, trail stop levels tightly over the next 4-6 weeks; this is a sentiment-sensitive name where a single quarter of merely in-line execution can compress the multiple before fundamentals catch up.
• Monitor for M&A chatter in martech/adtech over the next 6-12 months; ZETA’s execution can make it an acquirer or a target, and either outcome could create a valuation catalyst beyond organic growth alone.